Jane Street
BIOR

Jane Street’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Jane Street’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-83
Closed -$2.74K – 10603
2022
Q4 		$2.74K Sell
83
-50
-38% -$3.65K ﹤0.01% 8917
2022
Q3 		$16K Sell
133
-1,311
-91% -$236K ﹤0.01% 9257
2022
Q2 		$253K Sell
1,444
-334
-19% -$70.4K ﹤0.01% 7862
2022
Q1 		$516K Buy
1,778
+797
+81% +$302K ﹤0.01% 7423
2021
Q4 		$513K Buy
981
+723
+280% +$519K ﹤0.01% 7227
2021
Q3 		$98K Buy
+258
New +$111K ﹤0.01% 9312

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Jane Street's BIOR Position: Q2 2024 in Review

Jane Street sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q2 2024, closing a stake of 1,778 shares — an estimated $19.6K sold.

Jane Street first reported a position in BIOR in Q4 2020 and held it in 8 quarters. The position peaked at $534K in Q4 2021. 26 funds tracked by Wall St. Rank hold BIOR as of Q2 2024.

  • Jane Street reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Jane Street sold 1,778 Biora Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $19.6K.
  • Jane Street first reported a position in Biora Therapeutics, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
  • Jane Street's Biora Therapeutics, Inc. Common Stock position peaked at $534K in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Jane Street's 13F filing for Q2 2024, filed 15 Aug 2024.